Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of RNA binding proteins in intervertebral disc degeneration and osteoarthritis. | Orthop Surg | 2023 | 37803912 | PubTator, text mining | PubMed |
| Spontaneous regression of tumours. Possible cross reactivity of autoantibodies against carbonic anhydrase I. | J Cell Mol Med | 2023 | 37776059 | PubTator, text mining | PubMed |
| Molecular Resonance Imaging of the CAIX Expression in Mouse Mammary Adenocarcinoma Cells. | Pharmaceuticals (Basel) | 2023 | 37765110 | PubTator, text mining | PubMed |
| Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase. | Molecules | 2023 | 37764294 | PubTator, text mining | PubMed |
| Chemical biology tools for protein labelling: insights into cell-cell communication. | Biochem J | 2023 | 37732646 | PubTator, text mining | PubMed |
| Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. | Cancers (Basel) | 2023 | 37686693 | PubTator, text mining | PubMed |
| Recurrent Implantation Failure: Bioinformatic Discovery of Biomarkers and Identification of Metabolic Subtypes. | Int J Mol Sci | 2023 | 37686293 | PubTator, text mining | PubMed |
| Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells. | Int J Mol Sci | 2023 | 37685842 | PubTator, text mining | PubMed |
| A Review: Methodologies to Promote the Differentiation of Mesenchymal Stem Cells for the Regeneration of Intervertebral Disc Cells Following Intervertebral Disc Degeneration. | Cells | 2023 | 37681893 | PubTator, text mining | PubMed |
| The potential effects and mechanism of echinacoside powder in the treatment of Hirschsprung's Disease. | Math Biosci Eng | 2023 | 37679133 | PubTator, text mining | PubMed |
| Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages. | J Nanobiotechnology | 2023 | 37667246 | PubTator, text mining | PubMed |
| First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study. | EJNMMI Res | 2023 | 37665396 | PubTator, text mining | PubMed |
| Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37663266 | PubTator, text mining | PubMed |
| Verbascoside: A neuroprotective phenylethanoid glycosides with anti-depressive properties. | Phytomedicine | 2023 | 37657207 | PubTator, text mining | PubMed |
| Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII. | J Enzyme Inhib Med Chem | 2023 | 37655449 | PubTator, text mining | PubMed |
| Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study. | BMC Microbiol | 2023 | 37644393 | PubTator, text mining | PubMed |
| Nomogram of uveal melanoma as prediction model of metastasis risk. | Heliyon | 2023 | 37609406 | PubTator, text mining | PubMed |
| Trafficking of carbonic anhydrase 12 and bicarbonate transporters by histamine stimulation mediates intracellular acidic scenario in lung cancer cells. | J Enzyme Inhib Med Chem | 2023 | 37587861 | PubTator, text mining | PubMed |
| A unique presentation of hyponatremia and seizures in a 2-month-old child with cystic fibrosis: a case report. | Ann Med Surg (Lond) | 2023 | 37554905 | PubTator, text mining | PubMed |
| TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. | PLoS One | 2023 | 37535601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=9